Form 4: STAAR Surgical Executive Awarded Restricted Stock Units
SEC Form 4 Filing
Magda Michna, Chief Development Officer of STAAR Surgical, received restricted stock units (RSUs) as part of an annual equity award and in connection with her promotion.
Summary
- Magda Michna, Chief Development Officer of STAAR Surgical, was granted restricted stock units (RSUs) on March 14, 2025.
- 43,989 RSUs were granted as part of her annual equity award.
- 8,798 RSUs were granted in connection with her promotion to Chief Development Officer.
- The RSUs vest in three equal installments on March 14, 2026, March 14, 2027, and March 14, 2028.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, indicating stability and alignment of interests.
Positives
- The grant of RSUs to the Chief Development Officer suggests the company is incentivizing and rewarding key personnel.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain any specific forward-looking statements beyond the vesting schedule of the RSUs.
Industry Context
Equity compensation is a common practice in the medical device industry to attract and retain talent. The size and vesting schedule of the RSU grant are typical for executive compensation packages.
Comparison to Industry Standards
- Comparing STAAR Surgical's equity compensation practices to companies like Alcon, Johnson & Johnson (medical device sector), and Medtronic reveals that RSUs are a standard component of executive pay.
- The vesting schedules, typically three to four years, are also in line with industry norms.
- The specific value of the RSUs as a percentage of total compensation would require further analysis of the executive's overall package.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Development Officer | Unknown | Magda Michna | 03/14/2025 | Promotion |
Stakeholder Impact
- Shareholders may view the RSU grant as a positive incentive for the Chief Development Officer to drive long-term growth.
- Employees may see this as a sign of the company's commitment to rewarding performance and promoting from within.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of RSU grant |
| 03/14/2026 | First vesting date (1/3 of RSUs) |
| 03/14/2027 | Second vesting date (1/3 of RSUs) |
| 03/14/2028 | Final vesting date (1/3 of RSUs) |
| 03/18/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.